These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8144442)

  • 1. Activity of beta-lactam antibiotics in an animal model against methicillin-resistant Staphylococcus aureus.
    Ling JM; Lam AW; Cheng AF; French GL
    J Antimicrob Chemother; 1993 Dec; 32(6):919-20. PubMed ID: 8144442
    [No Abstract]   [Full Text] [Related]  

  • 2. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
    J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.
    Charles PG; Ward PB; Johnson PD; Howden BP; Grayson ML
    Clin Infect Dis; 2004 Feb; 38(3):448-51. PubMed ID: 14727222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin minimum inhibitory concentrations and outcome in patients with severe Staphylococcus aureus infection.
    Gould IM
    J Infect Dis; 2012 Mar; 205(5):864-5; author reply 865-6. PubMed ID: 22238463
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment triangle for staphylococcal infections.
    Grayson ML
    N Engl J Med; 2006 Aug; 355(7):724-7. PubMed ID: 16914709
    [No Abstract]   [Full Text] [Related]  

  • 6. [Methicillin resistant Staphylococcus aureus].
    Shimada K
    Nihon Naika Gakkai Zasshi; 1992 Mar; 81(3):436-40. PubMed ID: 1607813
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
    Vikram HR; Havill NL; Koeth LM; Boyce JM
    J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of methicillin-resistant Staphylococcus aureus infection with quinupristin/dalfopristin.
    Torralba MD; Frey SE; Lagging LM
    Clin Infect Dis; 1995 Aug; 21(2):460-1. PubMed ID: 8562776
    [No Abstract]   [Full Text] [Related]  

  • 9. [Bacteremia due to methicillin-resistant Staphylococcus aureus (MRSA)].
    Funada H
    Nihon Rinsho; 1992 May; 50(5):1081-6. PubMed ID: 1507431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group.
    Smith TL; Pearson ML; Wilcox KR; Cruz C; Lancaster MV; Robinson-Dunn B; Tenover FC; Zervos MJ; Band JD; White E; Jarvis WR
    N Engl J Med; 1999 Feb; 340(7):493-501. PubMed ID: 10021469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vancomycin-resistant Staphylococcus aureus occurs in South Africa.
    Ferraz V; Dusé AG; Kassel M; Black AD; Ito T; Hiramatsu K
    S Afr Med J; 2000 Nov; 90(11):1113. PubMed ID: 11196030
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia.
    Khatib R; Saeed S; Sharma M; Riederer K; Fakih MG; Johnson LB
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):181-5. PubMed ID: 16505987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.
    Huang YT; Hsiao CH; Liao CH; Lee CW; Hsueh PR
    J Clin Microbiol; 2008 Mar; 46(3):1132-6. PubMed ID: 18199793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future strategies for treating Staphylococcus aureus bloodstream infections.
    Naber CK
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Chambers HF; Sachdeva M; Kennedy S
    J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of methicillin-resistant Staphylococcus aureus bacteremia.
    Cosgrove SE; Fowler VG
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S386-93. PubMed ID: 18462094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of persistent bacteremia caused by methicillin-resistant Staphylococcus aureus: a survey of infectious diseases consultants.
    Hageman JC; Liedtke LA; Sunenshine RH; Strausbaugh LJ; McDonald LC; Tenover FC;
    Clin Infect Dis; 2006 Sep; 43(5):e42-5. PubMed ID: 16886141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.
    Mangili A; Bica I; Snydman DR; Hamer DH
    Clin Infect Dis; 2005 Apr; 40(7):1058-60. PubMed ID: 15825002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-lactam antibiotics active against methicillin-resistant Staphylococcus aureus.
    Moreillon P; Franciolli M; Cantoni L; Bille J; Glauser MP
    J Infect Dis; 1991 May; 163(5):1165-6. PubMed ID: 2064675
    [No Abstract]   [Full Text] [Related]  

  • 20. Audit of the management of Staphylococcus aureus bloodstream infection: gaps to be plugged.
    Barry A; McNicholas S; Smyth E; Humphreys H; Fitzpatrick F
    J Hosp Infect; 2010 Nov; 76(3):272-3. PubMed ID: 20435374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.